Back to search

Article

Challenges and prospects of cell-free DNA in precision oncology

2024-11-09

Abstract excerpt

Cell-free DNA (cfDNA), predominantly derived from apoptotic or necrotic cells, is emerging as a potential biomarker due to non-invasiveness and cost-effectiveness 1 . Additionally, another type of cfDNA such as cell-free mitochondrial DNA (cf-mtDNA) that is released from cells under stress or damage condition, may play a key role in the immune system. Thus, the presence of cfDNA in the circulation of cancer patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
53710e79-26e2-58fc-97ec-a9c4378a14eb
DOI
10.1016/j.medp.2024.100059
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Challenges and prospects of cell-free DNA in precision oncologyDOI 10.1016/j.medp.2024.100059
Select a neighboring publication to make it the new centre.